![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3MB |
![[thumbnail of Supplementary Materials]](https://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supplementary Materials)
10MB |
| Item Type: | Article |
|---|---|
| Title: | YAP1 enhances mesenchymal-type gene expression in human adrenergic-type neuroblastoma cells |
| Creators Name: | Ludwig, Marius, Ahrens, Kerstin, Winkler, Annika, Wünschel, Jasmin, Ruka, Peris, Lodrini, Marco, Hertwig, Falk, Castelli, Sveva, Thole-Kliesch, Theresa M., Hollander, Jan F., Fuchs, Steffen, Künkele, Annette, Jens, Marvin, Mamlouk, Soulafa, Warmann, Steven W., Astrahantseff, Kathy, Eggert, Angelika, Schulte, Johannes H., Szymansky, Annabell and Deubzer, Hedwig E. |
| Abstract: | BACKGROUND/OBJECTIVES: Neuroblastoma cells are phenotypically plastic, transitioning between mesenchymal and adrenergic states. Core functional genes (e.g., YAP1) mark the mesenchymal state, which is linked to unfavorable prognosis. We and others previously demonstrated relapse-specific Hippo-YAP pathway activation in matched primary/relapsed neuroblastomas. Here we explored the role of YAP1 in neuroblastoma aggressiveness and response to therapy. METHODS: RT-qPCR and immunoblotting assessed YAP1 expression in neuroblastoma cell lines. RNA-sequencing detected YAP1-dependent gene signatures in Tet-ON SK-N-AS and SH-EP neuroblastoma cell models expressing wildtype YAP1 or constitutively activated YAP1(S127A). Data from cell models were compared with our published YAP1 expression data from neuroblastomas. Efficacy of commonly used chemotherapeutics was comparatively analyzed in the cell models. RESULTS: YAP1 expression showed marked variability across a panel of neuroblastoma cell lines, assessed by mRNAanalysis in 10 cell lines and protein analysis in a subset of 9 cell lines. RNA sequencing in constitutively activated YAP1(S127A) mutant and wildtype YAP1 models detected 2162 and 1837 significantly differentially expressed genes in the SK-N-AS and SH-EP backgrounds, respectively. Continuously activating YAP1 in SK-N-AS cells upregulated mesenchymal signature genes and mesenchymal-associated transcription factors. Gene expression influenced by YAP1 activity in the cell models significantly overlapped with YAP1-associated genes (e.g., CYR61 and SPRY4) in published tumor data. Functionally, YAP1(S127A) expression rendered neuroblastoma cells resistant to chemotherapy. CONCLUSIONS: Findings corroborate the idea of a mechanistic role for YAP1 in neuroblastoma adrenergic to mesenchymal reprogramming and therapy resistance. The YAP1-mediated plastic switch towards a mesenchymal expression state in neuroblastoma cells may provide the molecular basis for novel therapeutic avenues. |
| Keywords: | Pediatric Cancer, Embryonal Tumor, Phenotypic Plasticity, Drug Resistance, Relapse, RNA Sequencing, Gene Expression Signature |
| Source: | Cancers |
| ISSN: | 2072-6694 |
| Publisher: | MDPI |
| Volume: | 18 |
| Number: | 3 |
| Page Range: | 383 |
| Date: | February 2026 |
| Official Publication: | https://doi.org/10.3390/cancers18030383 |
| PubMed: | View item in PubMed |
| Related to: |
Repository Staff Only: item control page
